Literature DB >> 25633785

Regulatory watch: Innovation in biologic new molecular entities: 1986-2014.

Kathleen L Miller1, Michael Lanthier1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25633785     DOI： 10.1038/nrd4535

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Can next-generation antibodies offset biosimilar competition?

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694
  1 in total
  7 in total

1.  Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition.

Authors:  Ronald P Evens
Journal:  AAPS J       Date:  2016-01       Impact factor: 4.009

Review 2.  Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development.

Authors:  Dheeraj S Tomar; Sandeep Kumar; Satish K Singh; Sumit Goswami; Li Li
Journal:  MAbs       Date:  2016-01-06       Impact factor: 5.857

3.  Systematic literature review of the methodology for developing pharmacotherapeutic interchange guidelines and their implementation in hospitals and ambulatory care settings.

Authors:  Maria Adrover-Rigo; Maria-Dolores Fraga-Fuentes; Francesc Puigventos-Latorre; Iciar Martinez-Lopez
Journal:  Eur J Clin Pharmacol       Date:  2018-10-19       Impact factor: 2.953

4.  A novel approach to support implementation of biosimilars within a UK tertiary hospital.

Authors:  Katherine Saxby; Sonali Sanghvi; Pritesh N Bodalia; Robin E Ferner; Maria Leandro; Robert Urquhart; Reecha Sofat
Journal:  Br J Clin Pharmacol       Date:  2019-12-20       Impact factor: 4.335

Review 5.  Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

6.  Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis.

Authors:  Jing Luo; Shunlong Ou; Hua Wei; Xiaoli Qin; Qian Jiang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

7.  Matched Peptides: Tuning Matched Molecular Pair Analysis for Biopharmaceutical Applications.

Authors:  Julian E Fuchs; Bernd Wellenzohn; Nils Weskamp; Klaus R Liedl
Journal:  J Chem Inf Model       Date:  2015-11-06       Impact factor: 4.956
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.